[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Edgewise Therapeutics, Inc. Common Stock](/topic/$ewtx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +30%  
**1 Month**: XX% -XX%  
**6 Months**: XX% +1%  
**1 Year**: XX% +4%  
**1-Year High**: XXX% on 2025-01-29  
**1-Year Low**: XX% on 2025-03-21  

**Most Supportive Themes**
- **Positive Data and Presentations:** (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, with positive commentary from analysts and investors.
- **Analyst Coverage and Ratings:** (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
- **Mentions in Biotech Watchlists:** (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.
  
**Most Critical Themes**
- **Market Volatility:** (10%)  The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %  |
| ------- | -------- | -  | ------- | -  | -------- | -  |
| X       | X        | X% | XX      | X% | XX       | X% |
|         |          |    |         |    |          |    |
| Total   | XX       | X% | XX      | X% | X        | X% |